NASDAQ$HQY

HealthEquity Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

HealthEquity demonstrated growth and profitability, driven by an increase in new HSA members and improved Adjusted EBITDA margin.

HealthEquity reported a 19% increase in revenue, reaching $244.4 million for the first quarter ended April 30, 2023. Net income was $4.1 million, a significant improvement from the previous year's net loss of $13.6 million. The company added 134,000 new HSA members and increased its Adjusted EBITDA margin by 700 basis points year-over-year.

  • Revenue increased by 19% to $244.4 million compared to Q1 FY23.
  • Net income was $4.1 million, a significant turnaround from the $13.6 million net loss in Q1 FY23.
  • Non-GAAP net income increased by 89% to $42.8 million compared to Q1 FY23.
  • The company added 134,000 new HSA members during the quarter.

Headline financials

Total Revenue

$244M

Previous: $206M+18.8%
EPS (adj)

$0.50

Previous: $0.27+85.2%
Total HSAs

8.0M

Previous: 7.4M+8.1%
HSAs with Investments

556.0K

Previous: 506.0K+9.9%
Total Accounts

15.0M

Previous: 14.5M+3.4%
Average Total Accounts - QTD

15.0M

No prior period
New HSAs from Sales - QTD

134

Previous: 159.0K-99.9%
Capital Expenditures

-$132K

Previous: -$1.16M+88.6%
Free Cash Flow

$3.96M

Previous: -$14.8M+126.8%
Net Income

$4.09M

Previous: -$13.6M+130.0%
Operating Income

$23.2M

Previous: -$7.29M+418.0%
Gross Profit

$148M

Previous: $111M+33.0%
Cash & Equivalents

$226M

Previous: $161M+39.9%
Total Assets

$3.04B

Previous: $3.07B-1.0%
Stock-Based Comp

$18.2M

Previous: $14M+30.2%

Revenue & EPS history

HealthEquity · Revenue · Quarterly

$244M

Q1 2024+18.8%vs Q1 2023
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

HealthEquity · $244M total across 3 segments · Q1 2024

  • Service Revenue
    $105M+0.7%
  • Custodial Revenue
    $94.4M+59.1%
  • Interchange Revenue
    $44.9M+6.9%

Forward guidance

For the fiscal year ending January 31, 2024, HealthEquity expects revenue of $975 million to $985 million and net income between $9 million and $14 million, resulting in net income of $0.10 to $0.16 per diluted share. Non-GAAP net income is projected to be between $164 million and $171 million, or $1.88 to $1.97 per diluted share. Adjusted EBITDA is expected to be $333 million to $343 million.

Tailwinds

  • Revenue is projected to be between $975 million and $985 million.
  • Net income is expected to be between $9 million and $14 million.
  • Non-GAAP net income is projected to be between $164 million and $171 million.
  • Adjusted EBITDA is expected to be between $333 million and $343 million.
  • Non-GAAP net income per diluted share is projected to be $1.88 to $1.97.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-0.4%

Avg return

Earnings day

-1.9%

Avg return

5 days after

-1.1%

Avg return

30 days after

55%

29 / 53 earnings

Positive

+10.8%

Q1 2024

Best reaction

-22.2%

Q4 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2027
Q4 2026+0.7%+2.8%+8.4%
Q3 2026-2.9%-5.5%-7.7%
Q2 2026+7.6%+4.7%-0.3%
Q1 2026+9.1%+7.1%-1.5%
Q4 2025-17.1%-11.2%-16.9%
Q3 2025-4.8%-4.6%-0.5%
Q2 2025+3.9%-4.2%-1.7%
Q1 2025+2.1%+4.4%+2.3%
Q4 2024-1.9%-4.0%-3.7%
Q3 2024+0.4%-0.8%-0.7%
Q2 2024+4.4%+2.4%+9.4%
Q1 2024+10.8%+9.4%+6.1%
Q4 2023+0.8%-1.1%+0.7%
Q3 2023-2.3%-7.7%-9.8%
Q2 2023+0.1%+4.6%+5.5%
Q1 2023+2.0%-0.0%-4.8%
Q4 2022+2.4%+11.3%+20.3%
Q3 2022-21.3%-24.8%-14.4%
Q2 2022+1.2%-1.4%-0.8%
Q1 2022+0.4%-3.2%-1.6%
Q4 2021-5.9%-9.4%-11.8%
Q3 2021-3.7%-8.5%+8.1%
Q2 2021+5.4%-11.8%-6.2%
Q1 2021-6.6%+5.9%-5.6%
Q4 2020-22.2%-17.9%-15.1%
Q3 2020+2.9%+9.6%+17.4%
Q2 2020-6.1%-6.3%-8.1%
Q1 2020+1.7%+6.0%-0.4%
Q4 2019+2.9%-10.2%-23.8%
Q3 2019-17.5%-23.8%-38.8%
Q2 2019+2.9%+3.0%-3.9%
Q1 2019+4.8%+4.6%+1.1%
Q4 2018+8.7%+6.7%+11.3%
Q3 2018-5.8%-6.4%-1.7%
Q2 2018+7.3%+6.0%+23.1%
Q1 2018+8.8%+7.4%-0.2%
Q4 2017-4.6%-12.1%-0.9%
Q3 2017-1.1%-2.4%-2.8%
Q2 2017+3.0%-0.7%+13.1%
Q1 2017+7.9%+7.4%+11.7%
Q4 2016+5.2%
Q3 2016-4.6%
Q2 2016+6.5%
Q1 2015-0.1%
Q1 2016+3.2%
Q4 2013-0.1%
Q1 2014-0.1%
Q4 2015-1.0%
Q3 2014-8.0%
Q3 2015+0.7%
Q2 2015-0.3%
Q4 2014-0.3%
Q2 2014-0.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro